ABL Kinase Domain Pseudoexon Insertion Is Not Uncommon in BCR-ABL Transcripts

ABL Kinase Domain Pseudoexon Insertion Is Not Uncommon in BCR-ABL Transcripts

Abstract

Abstract This Correspondence relates to "An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy" (J Mol Diagn 2008, 10:177–180). Authors’ Reply: Jennifer Laudadio Wake Forest University, Winston-Salem, North Carolina Richard D. Press Oregon Health and Science University, Portland, Oregon